{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:24:04Z","timestamp":1788452644310,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000971","name":"Diabetes Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008415","name":"Diabetesliitto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1105467"],"award-info":[{"award-number":["1105467"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1024105"],"award-info":[{"award-number":["1024105"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["457103"],"award-info":[{"award-number":["457103"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1137071"],"award-info":[{"award-number":["1137071"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1121272"],"award-info":[{"award-number":["1121272"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2018537"],"award-info":[{"award-number":["2018537"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1037786"],"award-info":[{"award-number":["1037786"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007811","name":"Sydney Medical School Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.diabres.2025.112080","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:39:06Z","timestamp":1741696746000},"page":"112080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Relationship of haptoglobin phenotype and levels with sight-threatening diabetic retinopathy in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in diabetes (FIELD) substudy"],"prefix":"10.1016","volume":"222","author":[{"given":"Kwok Leung","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0995-4524","authenticated-orcid":false,"given":"Andrzej S.","family":"Januszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar","family":"Mangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-6480","authenticated-orcid":false,"given":"Russell S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Keech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112080_b0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/ijms22010287","article-title":"The role of haptoglobin polymorphism in cardiovascular disease in the setting of diabetes","volume":"22","author":"Somer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2025.112080_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2337\/diaclin.34.3.148","article-title":"Role of haptoglobin in health and disease: a focus on diabetes","volume":"34","author":"MacKellar","year":"2016","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.diabres.2025.112080_b0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.107.149435","article-title":"Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability","volume":"101","author":"Levy","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2025.112080_b0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ejim.2007.02.033","article-title":"Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: an Egyptian study","volume":"18","author":"Bessa","year":"2007","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.diabres.2025.112080_b0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/ATVBAHA.107.153965","article-title":"Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial","volume":"28","author":"Milman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2025.112080_b0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.11.051","article-title":"Haptoglobin phenotype modifies the influence of intensive glycemic control on cardiovascular outcomes","volume":"75","author":"Carew","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2025.112080_b0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/dc21-1429","article-title":"Haptoglobin phenotype modifies the effect of fenofibrate on risk of coronary event: ACCORD lipid trial","volume":"45","author":"Warren","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112080_b0040","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.112080_b0045","doi-asserted-by":"crossref","unstructured":"ACCORD Study Group; ACCORD Eye Study Group; Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010;363:233\u201344.","DOI":"10.1056\/NEJMoa1001288"},{"key":"10.1016\/j.diabres.2025.112080_b0050","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400179","article-title":"Effect of fenofibrate on progression of diabetic retinopathy","volume":"3","author":"Preiss","year":"2024","journal-title":"NEJM Evid"},{"key":"10.1016\/j.diabres.2025.112080_b0055","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.112080_b0060","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1515\/cclm-2013-0018","article-title":"An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype","volume":"51","author":"Levy","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.diabres.2025.112080_b0065","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/jc.2019-00723","article-title":"Haptoglobin phenotype modulates lipoprotein-associated risk for preeclampsia in women with type 1 diabetes","volume":"104","author":"Kelly","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112080_b0070","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/jdi.14290","article-title":"Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate","volume":"15","author":"Januszewski","year":"2024","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2025.112080_b0075","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2025.112080_b0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00125-010-1951-1","article-title":"Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the fenofibrate intervention and event lowering in diabetes (FIELD) study","volume":"54","author":"Davis","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112080_b0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2337\/dc14-0180","article-title":"Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes","volume":"38","author":"Herrmann","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112080_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107865","article-title":"Serum haptoglobin levels are associated with renal function decline in type 2 diabetes mellitus patients in a Chinese Han population","volume":"156","author":"Huang","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2025.112080_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2195059","article-title":"The association of haptoglobin gene variants and retinopathy in type 2 diabetic patients: a meta-analysis","volume":"2017","author":"Wu","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2025.112080_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100851","article-title":"Haptoglobin: from hemoglobin scavenging to human health","volume":"73","author":"di Masi","year":"2020","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.diabres.2025.112080_b0105","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.26.5.1589","article-title":"New insights on oxidative stress and diabetic complications may lead to a \u201ccausal\u201d antioxidant therapy","volume":"26","author":"Ceriello","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112080_b0110","article-title":"Red blood cells as biomarkers and mediators in complications of diabetes mellitus: A review","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.diabres.2025.112080_b0115","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.RES.0000076889.23082.F1","article-title":"Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease","volume":"92","author":"Asleh","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2025.112080_b0120","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1055\/s-0031-1286325","article-title":"Impaired red blood cell deformability in patients with coronary artery disease and diabetes mellitus","volume":"43","author":"Keymel","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabres.2025.112080_b0125","doi-asserted-by":"crossref","first-page":"43603","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy","volume":"2007","author":"Kowluru","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.diabres.2025.112080_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109650","article-title":"A correlation between oxidative stress and diabetic retinopathy: an updated review","volume":"236","author":"Hussain","year":"2023","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.diabres.2025.112080_b0135","article-title":"Role of MMP-9 and NF-\u03baB in diabetic retinopathy: progression and potential role of bioflavonoids in the mitigation of diabetic retinopathy","volume":"31","author":"RituGoyal","year":"2024","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.diabres.2025.112080_b0140","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/jcp.22970","article-title":"Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions","volume":"227","author":"Miranda","year":"2012","journal-title":"J Cell Physiol"},{"issue":"Supp 1","key":"10.1016\/j.diabres.2025.112080_b0145","first-page":"A9","article-title":"Inflammation and oxidative stress in type 2 diabetes vascular complications: predictive power and effects of fenofibrate in the fenofibrate intervention and event lowering in diabetes study","volume":"60","author":"Jenkins","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.112080_b0150","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.2337\/db13-0800","article-title":"An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes","volume":"62","author":"Noonan","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.112080_b0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1751-553X.2007.00898.x","article-title":"Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases","volume":"29","author":"Carter","year":"2007","journal-title":"Int J Lab Hematol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:23:28Z","timestamp":1763706208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":31,"alternative-id":["S0168822725000944"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112080","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of haptoglobin phenotype and levels with sight-threatening diabetic retinopathy in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in diabetes (FIELD) substudy","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112080"}}